Building Your Care Team and Monitoring Your Health
At a Glance
POIKTMP requires coordinated, lifelong monitoring because it can affect the skin, lungs, liver, pancreas, growth, muscles, and tendons. A multidisciplinary team should tailor baseline tests and follow-up to the patient, while avoiding unnecessary testing or radiation.
Managing a diagnosis as complex and rare as POIKTMP requires more than just a single doctor; it requires a coordinated team of specialists. Because the condition can affect multiple organ systems—often at different times—the goal of your care team is to stay ahead of the disease through a proactive “surveillance” or monitoring strategy [1][2].
While there is no single established “rulebook” or consensus guideline for POIKTMP care, medical experts emphasize individualized screening of all relevant organ systems as soon as a diagnosis is confirmed [1][3].
Building Your Multidisciplinary Team
Your “medical home” should include specialists who communicate with one another to ensure no part of health is overlooked.
- Clinical Geneticist: To explain the FAM111B mutation and provide counseling for the family [4].
- Dermatologist: To monitor skin health (poikiloderma), hair loss, and manage issues related to reduced sweating [4].
- Pulmonologist: To perform respiratory screening, which includes checking how well the lungs are working and looking for signs of scarring (fibrosis) [3].
- Hepatologist: To monitor the liver for inflammation or scarring [5].
- Gastroenterologist/Nutritionist: To assess growth trends and check if the pancreas is producing enough digestive enzymes [4][6].
- Neuromuscular Specialist & Physical Therapist (PT): To monitor muscle strength and manage tendon contractures safely [4][7].
Baseline Evaluations: The First Steps
Once the diagnosis is made, your team will likely perform a series of “baseline” tests. These provide a snapshot of health that doctors can use for comparison in the future [1].
- Organ Imaging: This may include an abdominal ultrasound (to look at the liver) and potentially a lung evaluation [1][3].
- Blood Work: Initial labs typically check liver enzymes (AST, ALT) and general markers of inflammation [5][8].
- Muscle Assessment: A physical therapist will measure “range of motion” in the joints, particularly the ankles, and may recommend a baseline muscle MRI to look for fatty replacement in the muscles [4][7].
The Surveillance Schedule
Because POIKTMP is progressive, monitoring must continue throughout life. The proposed surveillance schedule below is based on limited expert proposals from clinical reports; the actual schedule, timing, and choice of tests must be highly individualized by the treating team to avoid unnecessary testing, radiation (like routine CT scans), or false reassurance.
Liver (Starting at 1 Month)
Because liver disease can begin very early, some experts propose that liver screening should start in the first month of life and continue with regular follow-ups [5]. This usually involves blood tests to check how well the liver is functioning [5][8].
Lungs (Upon Diagnosis)
Respiratory monitoring should begin as soon as the diagnosis is confirmed [3]. While pulmonary fibrosis is more common in adults, cases have been reported in children as young as 9 [8]. Your pulmonologist may use:
- Pulmonary Function Tests (PFTs): To measure lung capacity and air flow, depending on age and ability.
- Pulse Oximetry: To check oxygen levels in the blood, if clinically indicated. Home pulse oximetry or chest CTs should not be routine unless prescribed.
Pancreas and Growth
Growth (height and weight) should be tracked closely on a growth chart. If growth falters or if there are digestive symptoms, a fecal elastase test and nutritional assessment can check for exocrine pancreatic insufficiency [4][6].
Musculoskeletal (Ongoing)
Regular visits with a physical therapist are essential to safely monitor for “toe-walking” or muscle weakness characteristic of the condition [7]. They will help decide when braces (orthoses) or mobility aids are needed, while avoiding overworking the muscles [9][1].
Routine Care
Specialist surveillance is needed in addition to routine primary care. Vaccinations, dental care, mental-health support, and typical life activities remain just as important alongside managing this rare diagnosis.
| Organ System | Concern | Possible Assessments | Note |
|---|---|---|---|
| Liver | Inflammation, Fibrosis | Blood tests (AST, ALT), Ultrasound | Some experts propose screening starting in first month of life [5]. |
| Lungs | Pneumonitis, Fibrosis | PFTs, pulse oximetry, symptom check | Respiratory monitoring is crucial; timing depends on symptoms [3]. |
| Pancreas | Exocrine Insufficiency | Fecal elastase, nutritional check | Triggered by digestive symptoms or poor weight gain [4]. |
| Muscle | Myopathy, Contractures | Clinical range-of-motion exams | Focus on safety, mobility aids, and avoiding muscle exhaustion [7]. |
Common questions in this guide
Which specialists usually care for someone with POIKTMP?
What tests are used to monitor POIKTMP?
When should liver monitoring begin in POIKTMP?
How are lung problems monitored in POIKTMP?
What should families watch for in pancreatic insufficiency?
How can physical therapy help with POIKTMP?
Get notified when new evidence is published on Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Hereditary fibrosing poikiloderma (POIKTMP syndrome) report of a new mutation and review of the literature.
Hoeger PH, Koehler LM, Reipschlaeger M, Mercier S
Pediatric dermatology 2023; (40(1)):182-187 doi:10.1111/pde.15133.
PMID: 36102338 - 2
Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up.
Vignard V, Maillasson M, Bigot A, et al.
EBioMedicine 2025; (119()):105864 doi:10.1016/j.ebiom.2025.105864.
PMID: 40840166 - 3
[Pulmonary fibrosis associated with hereditary fibrosing poikiloderma caused by FAM111B mutation: A case report].
Sanchis-Borja M, Pastré J, Mercier S, et al.
Revue des maladies respiratoires 2018; (35(9)):968-973 doi:10.1016/j.rmr.2018.09.002.
PMID: 30341002 - 4
Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations.
Mercier S, Küry S, Salort-Campana E, et al.
Orphanet journal of rare diseases 2015; (10()):135 doi:10.1186/s13023-015-0352-4.
PMID: 26471370 - 5
Expanding phenotype of FAM111B-related disease focusing on liver involvement: Literature review, report of a case with end-stage liver disease and proposal for a new acronym.
Macchiaiolo M, Panfili FM, Vecchio D, et al.
American journal of medical genetics. Part A 2022; (188(10)):2920-2931 doi:10.1002/ajmg.a.62906.
PMID: 35869874 - 6
[Research progress of genetic research on POIKTMP syndrome].
Yang H, Xiang R, Fan L
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2026; (43(3)):228-233 doi:10.3760/cma.j.cn511374-20250623-00383.
PMID: 41916890 - 7
Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia.
Takimoto-Sato M, Miyauchi T, Suzuki M, et al.
Frontiers in genetics 2022; (13()):870192 doi:10.3389/fgene.2022.870192.
PMID: 35601499 - 8
Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype.
Ferré EMN, Yu Y, Oikonomou V, et al.
Frontiers in immunology 2023; (14()):1133387 doi:10.3389/fimmu.2023.1133387.
PMID: 36875114 - 9
Assessment and treatment of spastic equinovarus foot after stroke: Guidance from the Mont-Godinne interdisciplinary group.
Deltombe T, Wautier D, De Cloedt P, et al.
Journal of rehabilitation medicine 2017; (49(6)):461-468 doi:10.2340/16501977-2226.
PMID: 28451697
This page explains POIKTMP care coordination and surveillance for education only; it does not replace medical advice. Your care team should individualize tests and timing for your health or your child’s health.